日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway

MSMO1通过PERK/eIF2α/ATF4/CHOP通路调控T-MAS代谢,从而促进化疗耐药。

Ren, Hengyu; Wang, Xuliren; Shao, Zhibo; Xiong, Min; Chi, Weiru; Sang, Yuting; Zhang, Qi; Wang, Zehao; Liu, Douwaner; Zhang, Liyi; Chen, Ming; Zhu, Han; Xue, Jingyan; Xiu, Bingqiu; Chi, Yayun; Wu, Jiong

Author Correction: R-loop-dependent promoter-proximal termination ensures genome stability

作者更正:R环依赖的启动子近端终止确保基因组稳定性

Xu, Congling; Li, Chengyu; Chen, Jiwei; Xiong, Yan; Qiao, Zhibin; Fan, Pengyu; Li, Conghui; Ma, Shuangyu; Liu, Jin; Song, Aixia; Tao, Bolin; Xu, Tao; Xu, Wei; Chi, Yayun; Xue, Jingyan; Wang, Pu; Ye, Dan; Gu, Hongzhou; Zhang, Peng; Wang, Qiong; Xiao, Ruijing; Cheng, Jingdong; Zheng, Hai; Yu, Xiaoli; Zhang, Zhen; Wu, Jiong; Liang, Kaiwei; Liu, Yan-Jun; Lu, Huasong; Chen, Fei Xavier

XBP1s Mediates Cross-resistance to Combination Treatment of CDK4/6 Inhibitors plus Endocrine Therapy in Breast Cancer.

XBP1s介导乳腺癌中CDK4/6抑制剂联合内分泌治疗的交叉耐药性。

Sang Yuting, Liu Shiyang, Zhou Xujie, Chi Weiru, Xiong Min, Chen Ming, Ren Hengyu, Liu Douwaner, Zhang Liyi, Xue Jingyan, Chi Yayun, Wu Jiong

LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer.

LINC01235 通过 DNA 复制许可诱导的染色体不稳定性促进乳腺癌的克隆进化

Zhang Qi, Wang Xuliren, Shao Zhibo, Zhang Yi, Zhang Liyi, Chen Ming, Zhou Xujie, Zhu Han, Zhou Yue, Lu Xinya, Li Pei, Chi Weiru, Li Lun, Shao Zhi-Ming, Huang Shenglin, Xue Jingyan, Chi Yayun, Wu Jiong, Xiu Bingqiu

PPARG Activation of Fatty Acid Metabolism Drives Resistance to Anti-HER2 Therapies in HER2-Positive Breast Cancer

PPARG激活脂肪酸代谢驱动HER2阳性乳腺癌对HER2抑制剂的耐药性

Xiong, Min; Liu, Douwaner; Wang, Xuliren; Ren, Hengyu; Chi, Weiru; Xiu, Bingqiu; Zhang, Qi; Zhang, Jiayu; Zhang, Liyi; Wang, Zehao; Chen, Ming; Xue, Jingyan; Chi, Yayun; Wu, Jiong

JCAD-Derived from Plasma Exosomes: Promoting Tumor Cell Progression and Predicting Poor Outcomes in Breast Cancer

源自血浆外泌体的JCAD:促进肿瘤细胞进展并预测乳腺癌不良预后

Liu, Douwaner; Xiong, Min; Chen, Xiaoting; Wang, Xuliren; Sang, Yuting; Liu, Shiyang; Zhang, Liyi; Chi, Weiru; Ren, Hengyu; Xiu, Bingqiu; Zhang, Qi; Chi, Yayun; Wu, Jiong; Xue, Jingyan

Deepath-MSI: a clinic-ready deep learning model for microsatellite instability detection in colorectal cancer using whole-slide imaging

Deepath-MSI:一种可用于临床的深度学习模型,利用全切片成像技术检测结直肠癌中的微卫星不稳定性。

Feng, Xu; Yin, Wenjuan; Ye, Qing; Chi, Yayun; Wen, Huer; Sun, Yifeng; Zheng, Jin; Wang, Qifeng; Wang, Qian; Zhao, Ming; Yuan, Lin; Xu, Qinghua; Su, Dan; Zhou, Xiaoyan

Comprehensive Pan-Cancer Analysis of RAC1 Decoding the Impact on Cancer Prognosis and B cell immune Regulation.

RAC1 的泛癌综合分析:解码其对癌症预后和 B 细胞免疫调节的影响

Shao Zhibo, Ren Hengyu, Wang Xuliren, Zhang Qi, Xue Jingyan, Chi Yayun, Xiu Bingqiu, Wu Jiong

Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study

新辅助蒽环类药物治疗后序贯托瑞普利单抗联合白蛋白紫杉醇治疗早期三阴性乳腺癌患者(NeoTENNIS):一项单臂II期研究

He, Min; Hao, Shuang; Ma, LinXiaoxi; Xiu, BingQiu; Yang, BenLong; Wang, ZeHao; Xue, JingYan; Chi, YaYun; Xiong, Min; Chen, JiaJian; Huang, XiaoYan; Liu, XiYu; Wu, SongYang; Xiao, Qin; Huang, Yan; Shui, RuoHong; Cao, AYong; Li, JunJie; Di, GenHong; Yang, WenTao; Hu, Xin; Liu, GuangYu; Yu, KeDa; Jiang, YiZhou; Wang, ZhongHua; Shao, ZhiMing; Wu, Jiong

Coordinated regulation of RNA polymerase II pausing and elongation progression by PAF1

PAF1对RNA聚合酶II暂停和延伸进程的协调调控

Wang, Zhenning; Song, Aixia; Xu, Hao; Hu, Shibin; Tao, Bolin; Peng, Linna; Wang, Jingwen; Li, Jiabei; Yu, Jiali; Wang, Li; Li, Ze; Chen, Xizi; Wang, Mengyun; Chi, Yayun; Wu, Jiong; Xu, Yanhui; Zheng, Hai; Chen, Fei Xavier